Pomdoctor Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	399.91	342.56	304.85	245.22	215.38
Revenue Growth	16.74%	12.37%	24.32%	13.85%	52.53%
Cost of Revenue	347.63	294.86	266.13	190.36	162.88
Gross Profit	52.28	47.69	38.72	54.86	52.51
Selling, General & Admin	155.94	68.24	55.99	54.87	102.95
Research & Development	12.86	3	3.37	3.59	4.28
Operating Expenses	168.81	71.25	59.36	58.46	107.23
Operating Income	-116.53	-23.55	-20.64	-3.59	-54.73
Interest Expense	-12.89	-12.96	-13.85	-16.02	-16.29
Other Non Operating Income (Expenses)	0.59	1.39	-0.85	-0.21	-0.22
EBT Excluding Unusual Items	-128.82	-35.13	-35.34	-19.83	-71.24
Gain (Loss) on Sale of Investments	-	-	-0.5	-	-
Asset Writedown	-2.11	-2.24	-1.11	-	-24.94
Other Unusual Items	-81.65	-105.97	-108.44	-105.68	-92.24
Pretax Income	-212.58	-143.34	-145.39	-125.51	-188.42
Income Tax Expense	0	-	-	-	-
Earnings From Continuing Operations	-212.58	-143.34	-145.39	-125.51	-188.42
Minority Interest in Earnings	0	-0.03	-0	0	0.02
Net Income	-212.58	-143.36	-145.39	-125.51	-188.4
Net Income to Common	-212.58	-143.36	-145.39	-125.51	-188.4
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	3	2	2	1	1
Shares Outstanding (Diluted)	3	2	2	1	1
Shares Change	53.41%	-	56.11%	-	-76.35%
EPS (Basic)	-65.88	-68.16	-69.12	-93.15	-139.83
EPS (Diluted)	-65.88	-68.16	-69.12	-93.15	-139.83
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-150.09	-16.17	-45.91	-22.02	-15.68
Free Cash Flow Per Share	-46.51	-7.69	-21.82	-16.34	-11.64
Gross Margin	13.07%	13.92%	12.70%	22.37%	24.38%
Operating Margin	-29.14%	-6.88%	-6.77%	-1.47%	-25.41%
Profit Margin	-53.16%	-41.85%	-47.69%	-51.18%	-87.47%
Free Cash Flow Margin	-37.53%	-4.72%	-15.06%	-8.98%	-7.28%
EBITDA	-116.38	-23.42	-20.53	14.08	-37.05
EBITDA Margin	-29.10%	-6.84%	-6.73%	5.74%	-17.20%
D&A For EBITDA	0.15	0.13	0.11	17.68	17.68
EBIT	-116.53	-23.55	-20.64	-3.59	-54.73
EBIT Margin	-29.14%	-6.88%	-6.77%	-1.47%	-25.41%
Revenue as Reported	399.91	342.56	304.85	245.22	-
Advertising Expenses	19.54	11.1	3.43	1.37	7.29

SEC Filings: 10-K · 10-Q